Number of alprazolam prescriptions in the U.S. 2004-2016

Number of alprazolam prescriptions in the U.S. from 2004 to 2016 (in millions)

by Matej Mikulic, last edited Nov 14, 2018
Number of alprazolam prescriptions in the U.S. 2004-2016 This statistic shows the total annual number of alprazolam prescriptions in the U.S. from 2004 to 2016, in millions. In 2004, alprazolam was prescribed nearly 18 million times. As of 2016, the number of prescriptions had risen to over 27 million. Alprazolam is is a potent, short-acting benzodiazepine anxiolytic — a minor tranquilizer, used for the treatment of anxiety disorders, especially of panic disorder, but also in the treatment of generalized anxiety disorder (GAD) or social anxiety disorder.
Show more

Number of alprazolam prescriptions in the U.S. from 2004 to 2016 (in millions)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Canadian pharmaceutical industry"
  • Global positioning
The most important statistics
  • Key figures
  • Regional comparison
  • Generics
  • Products and prices
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.